SHAREHOLDER ALERT: Gainey McKenna & Egleston Reminds Investors of Class Action Against MiMedx Group, Inc. and a Lead Plaintiff Deadline of April 20, 2015 -- MDXG


NEW YORK, March 27, 2015 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities that purchased the securities of MiMedx Group, Inc. ("MiMedx Group" or the "Company") (Nasdaq:MDXG) between February 26, 2014 and December 31, 2014, inclusive (the "Class Period"), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose during the Class Period that: (1) the Company was in violation of federal regulations by engaging in improper marketing and sales practices; and (2) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

At the end of the Class Period, on December 31, 2014, after the close of trading, the Company issued a press release announcing the receipt of a civil subpoena from the Office of Inspector General of the Department of Health and Human Services. On this news, MiMedx Group securities declined $1.79 per share, or more than 15%, to close at $9.74 per share on January 2, 2015, the next trading day.

If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at tjmckenna@gme-law.com or gegleston@gme-law.com.